Alzheimer's Disease Diagnostics Must Be Globally Accessible.
J Alzheimers Dis
; 84(4): 1453-1455, 2021.
Article
em En
| MEDLINE
| ID: mdl-34690142
ABSTRACT
Dementia and Alzheimer's disease (AD) are global health crises, with most affected individuals living in low- or middle-income countries. While research into diagnostics and therapeutics remains focused exclusively on high-income populations, recent technological breakthroughs suggest that low-cost AD diagnostics may soon be possible. However, as this disease shifts onto those with the least financial and structural ability to shoulder its burden, it is incumbent on high-income countries to develop accessible AD healthcare. We argue that there is a scientific and ethical mandate to develop low-cost diagnostics that will not only benefit patients in low-and middle-income countries but the AD field as a whole.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Fatores Socioeconômicos
/
Saúde Global
/
Comportamento Cooperativo
/
Disparidades em Assistência à Saúde
/
Doença de Alzheimer
/
Acessibilidade aos Serviços de Saúde
Tipo de estudo:
Diagnostic_studies
Limite:
Humans
Idioma:
En
Revista:
J Alzheimers Dis
Assunto da revista:
GERIATRIA
/
NEUROLOGIA
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Estados Unidos